HEADER TRANSFERASE/NUCLEAR PROTEIN 03-FEB-08 2RNY TITLE COMPLEX STRUCTURES OF CBP BROMODOMAIN WITH H4 ACK20 PEPTIDE COMPND MOL_ID: 1; COMPND 2 MOLECULE: CREB-BINDING PROTEIN; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 1081-1197; COMPND 5 EC: 2.3.1.48; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: HISTONE H4; COMPND 9 CHAIN: B; COMPND 10 FRAGMENT: UNP RESIDUES 14-28; COMPND 11 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 8 EXPRESSION_SYSTEM_VARIANT: BL21; SOURCE 9 EXPRESSION_SYSTEM_VECTOR_TYPE: VECTOR; SOURCE 10 EXPRESSION_SYSTEM_VECTOR: PET15B; SOURCE 11 MOL_ID: 2; SOURCE 12 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 13 ORGANISM_COMMON: HUMAN; SOURCE 14 ORGANISM_TAXID: 9606; SOURCE 15 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21; SOURCE 16 EXPRESSION_SYSTEM_TAXID: 511693; SOURCE 17 EXPRESSION_SYSTEM_STRAIN: BL21; SOURCE 18 EXPRESSION_SYSTEM_VARIANT: BL21; SOURCE 19 EXPRESSION_SYSTEM_VECTOR_TYPE: VECTOR; SOURCE 20 EXPRESSION_SYSTEM_VECTOR: PET15B KEYWDS BROMODOMAIN, HISTONE, CREB, CBP, P53, ACETYLATION, ACTIVATOR, KEYWDS 2 CHROMOSOMAL REARRANGEMENT, DISEASE MUTATION, HOST-VIRUS INTERACTION, KEYWDS 3 METAL-BINDING, METHYLATION, NUCLEUS, PHOSPHOPROTEIN, TRANSCRIPTION, KEYWDS 4 TRANSCRIPTION REGULATION, TRANSFERASE, ZINC, ZINC-FINGER, KEYWDS 5 CHROMOSOMAL PROTEIN, DNA-BINDING, NUCLEOSOME CORE, TRANSFERASE- KEYWDS 6 NUCLEAR PROTEIN COMPLEX EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR L.ZENG,Q.ZHANG,G.GERONA-NAVARRO,M.M.ZHOU REVDAT 4 15-NOV-23 2RNY 1 ATOM REVDAT 3 16-MAR-22 2RNY 1 REMARK SEQADV LINK REVDAT 2 24-FEB-09 2RNY 1 VERSN REVDAT 1 06-MAY-08 2RNY 0 JRNL AUTH L.ZENG,Q.ZHANG,G.GERONA-NAVARRO,N.MOSHKINA,M.M.ZHOU JRNL TITL STRUCTURAL BASIS OF SITE-SPECIFIC HISTONE RECOGNITION BY THE JRNL TITL 2 BROMODOMAINS OF HUMAN COACTIVATORS PCAF AND CBP/P300 JRNL REF STRUCTURE V. 16 643 2008 JRNL REFN ISSN 0969-2126 JRNL PMID 18400184 JRNL DOI 10.1016/J.STR.2008.01.010 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 1.0, CNS 1.0 REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 (CNS), BRUNGER, ADAMS, CLORE, GROS, NILGES AND REMARK 3 READ (CNS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 2RNY COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 12-FEB-08. REMARK 100 THE DEPOSITION ID IS D_1000150076. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 298 REMARK 210 PH : 6.5 REMARK 210 IONIC STRENGTH : 0.1 REMARK 210 PRESSURE : AMBIENT REMARK 210 SAMPLE CONTENTS : 0.5MM [U-100% 13C; U-100% 15N] REMARK 210 SODIUM PHOSPHATE, 100% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 3D 1H-13C NOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 800 MHZ; 500 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE; DRX REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : ARIA 2.1 REMARK 210 METHOD USED : SIMULATED ANNEALING, TORSION REMARK 210 ANGLE DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 200 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : STRUCTURES WITH THE LOWEST REMARK 210 ENERGY REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 SER A1078 -78.46 -84.44 REMARK 500 1 MET A1080 -82.23 -49.74 REMARK 500 1 ARG A1081 -28.20 -162.32 REMARK 500 1 LYS A1082 -116.22 -78.04 REMARK 500 1 LYS A1083 -67.37 -93.70 REMARK 500 1 ILE A1084 107.22 62.06 REMARK 500 1 PHE A1085 -155.17 -113.45 REMARK 500 1 GLN A1104 38.27 -81.74 REMARK 500 1 PRO A1110 -9.69 -46.27 REMARK 500 1 VAL A1115 75.68 -69.14 REMARK 500 1 ASP A1116 109.93 -56.69 REMARK 500 1 ILE A1128 -58.21 -146.43 REMARK 500 1 LYS A1130 -30.55 72.49 REMARK 500 1 PRO A1132 -70.46 -38.14 REMARK 500 1 MET A1133 162.93 56.85 REMARK 500 1 ASP A1134 142.82 179.64 REMARK 500 1 LEU A1135 -17.79 -43.95 REMARK 500 1 ILE A1138 -74.34 -62.22 REMARK 500 1 LYS A1139 -16.71 -48.20 REMARK 500 1 ARG A1140 -72.15 -84.53 REMARK 500 1 GLN A1148 -28.80 -170.63 REMARK 500 1 ARG A1169 19.26 54.40 REMARK 500 1 LYS A1170 -54.49 73.66 REMARK 500 1 VAL A1192 -72.08 -80.27 REMARK 500 1 ALA B 15 169.50 62.37 REMARK 500 1 HIS B 18 -110.77 57.16 REMARK 500 1 ARG B 19 -153.04 -68.77 REMARK 500 1 ALY B 20 -93.74 -53.24 REMARK 500 1 LEU B 22 -101.06 -53.80 REMARK 500 1 ARG B 23 77.28 48.09 REMARK 500 1 ASN B 25 117.59 63.72 REMARK 500 1 ILE B 26 -31.64 -148.94 REMARK 500 2 SER A1078 -0.53 -150.31 REMARK 500 2 HIS A1079 81.62 -178.81 REMARK 500 2 LYS A1082 -79.50 -137.06 REMARK 500 2 LYS A1083 -76.45 -142.57 REMARK 500 2 ILE A1084 116.18 62.53 REMARK 500 2 PHE A1085 -147.23 -118.65 REMARK 500 2 ASP A1105 -77.97 7.46 REMARK 500 2 PRO A1106 -8.89 -55.44 REMARK 500 2 PRO A1110 -6.71 -59.30 REMARK 500 2 GLN A1113 -50.26 -142.26 REMARK 500 2 PRO A1114 -145.06 -61.46 REMARK 500 2 VAL A1115 66.53 77.16 REMARK 500 2 PRO A1117 37.35 -80.74 REMARK 500 2 GLN A1118 -60.32 -138.53 REMARK 500 2 PRO A1132 -84.95 -38.64 REMARK 500 2 MET A1133 116.56 65.68 REMARK 500 2 LEU A1135 -22.71 -39.96 REMARK 500 2 ILE A1138 -74.99 -70.32 REMARK 500 REMARK 500 THIS ENTRY HAS 623 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL DBREF 2RNY A 1081 1197 UNP Q92793 CBP_HUMAN 1081 1197 DBREF 2RNY B 13 27 UNP P62805 H4_HUMAN 14 28 SEQADV 2RNY GLY A 1077 UNP Q92793 EXPRESSION TAG SEQADV 2RNY SER A 1078 UNP Q92793 EXPRESSION TAG SEQADV 2RNY HIS A 1079 UNP Q92793 EXPRESSION TAG SEQADV 2RNY MET A 1080 UNP Q92793 EXPRESSION TAG SEQRES 1 A 121 GLY SER HIS MET ARG LYS LYS ILE PHE LYS PRO GLU GLU SEQRES 2 A 121 LEU ARG GLN ALA LEU MET PRO THR LEU GLU ALA LEU TYR SEQRES 3 A 121 ARG GLN ASP PRO GLU SER LEU PRO PHE ARG GLN PRO VAL SEQRES 4 A 121 ASP PRO GLN LEU LEU GLY ILE PRO ASP TYR PHE ASP ILE SEQRES 5 A 121 VAL LYS ASN PRO MET ASP LEU SER THR ILE LYS ARG LYS SEQRES 6 A 121 LEU ASP THR GLY GLN TYR GLN GLU PRO TRP GLN TYR VAL SEQRES 7 A 121 ASP ASP VAL TRP LEU MET PHE ASN ASN ALA TRP LEU TYR SEQRES 8 A 121 ASN ARG LYS THR SER ARG VAL TYR LYS PHE CYS SER LYS SEQRES 9 A 121 LEU ALA GLU VAL PHE GLU GLN GLU ILE ASP PRO VAL MET SEQRES 10 A 121 GLN SER LEU GLY SEQRES 1 B 15 GLY GLY ALA LYS ARG HIS ARG ALY VAL LEU ARG ASP ASN SEQRES 2 B 15 ILE GLN MODRES 2RNY ALY B 20 LYS N(6)-ACETYLLYSINE HET ALY B 20 26 HETNAM ALY N(6)-ACETYLLYSINE FORMUL 2 ALY C8 H16 N2 O3 HELIX 1 1 LYS A 1086 GLN A 1104 1 19 HELIX 2 2 GLN A 1104 GLN A 1113 1 10 HELIX 3 3 ASP A 1116 GLY A 1121 1 6 HELIX 4 4 ASP A 1134 GLY A 1145 1 12 HELIX 5 5 GLU A 1149 ASN A 1168 1 20 HELIX 6 6 ARG A 1173 GLY A 1197 1 25 LINK C ARG B 19 N ALY B 20 1555 1555 1.33 LINK C ALY B 20 N VAL B 21 1555 1555 1.32 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1